Worth Watching: Fluidigm Corporation Stock Is At Yearly Low Now


Worth Watching: Fluidigm Corporation Stock Is At Yearly Low Now

The stock of Fluidigm Corporation (NASDAQ:FLDM) hit a new 52-week low and has $3.97 target or 12.00% below today’s $4.51 share price. The 7 months bearish chart indicates high risk for the $125.61 million company. The 1-year low was reported on Oct, 17 by Barchart.com. If the $3.97 price target is reached, the company will be worth $15.07 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 140,760 shares traded hands. Fluidigm Corporation (NASDAQ:FLDM) has declined 43.42% since March 14, 2016 and is downtrending. It has underperformed by 49.03% the S&P500.

Analysts await Fluidigm Corporation (NASDAQ:FLDM) to report earnings on November, 3. They expect $-0.54 EPS, down 80.00% or $0.24 from last year’s $-0.3 per share. After $-0.47 actual EPS reported by Fluidigm Corporation for the previous quarter, Wall Street now forecasts 14.89% negative EPS growth.

Fluidigm Corporation (NASDAQ:FLDM) Ratings Coverage

Out of 5 analysts covering Fluidigm (NASDAQ:FLDM), 4 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 80% are positive. Fluidigm has been the topic of 17 analyst reports since August 7, 2015 according to StockzIntelligence Inc. As per Wednesday, August 26, the company rating was initiated by Cantor Fitzgerald. The stock has “Buy” rating given by Mizuho on Friday, August 5. The company was maintained on Friday, October 30 by Mizuho. The rating was maintained by Mizuho with “Neutral” on Friday, August 7. The firm earned “Buy” rating on Friday, October 30 by Cantor Fitzgerald. The firm has “Buy” rating given on Friday, February 5 by Mizuho. The rating was maintained by Mizuho on Sunday, August 9 with “Hold”. On Thursday, August 27 the stock rating was maintained by Maxim Group with “Hold”. As per Friday, August 21, the company rating was upgraded by Zacks. The firm has “Buy” rating by Deutsche Bank given on Thursday, January 7.

According to Zacks Investment Research, “Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company’s products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California.”

Insitutional Activity: The institutional sentiment decreased to 0.82 in 2016 Q2. Its down 0.14, from 0.96 in 2016Q1. The ratio is negative, as 14 funds sold all Fluidigm Corporation shares owned while 31 reduced positions. 8 funds bought stakes while 29 increased positions. They now own 25.56 million shares or 9.86% less from 28.35 million shares in 2016Q1.
Blackrock Grp Limited has 11,747 shares for 0% of their US portfolio. Manufacturers Life Insur Commerce The accumulated 22,238 shares or 0% of the stock. Natl Bank Of New York Mellon Corp, a New York-based fund reported 185,974 shares. Northern Tru has invested 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Moreover, Orbimed Advsr Ltd Co has 0.16% invested in Fluidigm Corporation (NASDAQ:FLDM) for 1.75M shares. Columbia Wanger Asset Llc accumulated 0.19% or 1.78 million shares. Connor Clark And Lunn Invest Mgmt holds 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM) for 46,775 shares. California State Teachers Retirement System holds 0% or 60,987 shares in its portfolio. Moreover, Pnc Financial Svcs has 0% invested in Fluidigm Corporation (NASDAQ:FLDM) for 1,275 shares. Geode Mngmt Ltd Llc has invested 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Blackrock Inv Mngmt Llc reported 109,868 shares or 0% of all its holdings. Renaissance Tech Limited Liability has invested 0% of its portfolio in Fluidigm Corporation (NASDAQ:FLDM). Product Partners Ltd Liability Corporation owns 45,600 shares or 0.03% of their US portfolio. Moreover, Wells Fargo & Company Mn has 0% invested in Fluidigm Corporation (NASDAQ:FLDM) for 13,915 shares. Legal & General Public Ltd Liability Company holds 4,371 shares or 0% of its portfolio.

More recent Fluidigm Corporation (NASDAQ:FLDM) news were published by: Schaeffersresearch.com which released: “Analyst Downgrades: Fluidigm Corporation, Netflix, Inc., and Nokia Corp” on October 13, 2016. Also Fool.com published the news titled: “Why Fluidigm Corporation is Soaring Higher” on October 30, 2015. Fool.com‘s news article titled: “Why Shares in Fluidigm Corporation Are Bursting” with publication date: May 08, 2015 was also an interesting one.

FLDM Company Profile

Fluidigm Corporation, incorporated on March 29, 2007, creates, makes and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Firm sells instruments and consumables, including integrated fluidic circuits, assays and reagents, to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology (Ag-Bio) companies. The Firm operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. The Firm offers various types of products, which include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply